Physician profile
Timothy J Devitt
NPI 1164475323
$3,825.52
in general payments reported to CMS, 2019-2025
8 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $88.43 · 2021: $20.55 · 2022: $50.00 · 2023: $2,547 · 2024: $436 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,503 · Food and Beverage: $964 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Entertainment: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,503.17 |
| Food and Beverage | $963.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Entertainment | $305.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,071.17 | 2022-2024 | |
| Keystone Dental INC. | $643.89 | 2019-2025 | |
| Henry Schein, INC. | $500.00 | 2023 | |
| Nobel Biocare USA | $272.41 | 2019-2020 | |
| Patterson Companies, INC. | $167.00 | 2025 | |
| Zimmer Biomet Holdings, INC. | $97.02 | 2019-2023 | Omnimax |
| Straumann USA LLC | $57.67 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.36 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Devitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.